About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Temocillin Pharmacokinetic in Hemodialysis | Clinical Trials | Clareo Health

COMPLETEDPhase 4

Temocillin Pharmacokinetic in Hemodialysis

A Clinical Pharmacokinetic Study: Is Three Times Weekly Temocillin Appropriate for the Treatment of Severe Gram-negative Infections in Patients With ESRD Treated With Intermittent Hemodialysis?

NCT02285075•AZ Sint-Jan AV

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Gram-Negative Bacterial InfectionsRenal Failure Chronic Requiring Hemodialysis

Interventions

temocillin PK/PD in haemodialysis

Locations

2

Belgium

Locations (2)

AZ Sint-Jan Brugge Oostende AV

Bruges, Belgium

Louvain Drug Research Institute (LDRI)

Brussels, Belgium

Key Dates

Start Date

June 1, 2011

Primary Completion Date

December 1, 2014

Completion Date

December 1, 2014

Last Updated

January 5, 2016

Related Studies

RECRUITINGPhase 2

Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

NCT06135350

Gram Negative PneumoniaGram-Negative Bacterial Infections+1 more

COMPLETEDPhase 2

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

NCT06086626

Gram-Negative Bacterial Infections

COMPLETEDPhase 2

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

NCT04335539

Gram-negative Bacterial InfectionsBloodstream Infections (BSI)+5 more

COMPLETEDPhase 2

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

NCT04215991

Gram-negative Bacterial InfectionsHospital Acquired Bacterial Pneumonia (HABP)+2 more

Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant

NCT02088840

Complications of Organ Transplant Stem CellsGram-Negative Bacterial Infections

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT

NCT02962934

Gram-Negative Bacterial Infections

View all related studies

Sponsors

Lead Sponsor

AZ Sint-Jan AV

Collaborators

Paul Tulkens, Louvain drug research institute, belgium
Francoise Van Bambeke, Louvain drug research institute, belgium
Ana Miranda Bastos, Louvain drug research institute, belgium

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2016Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions